Ask the Experts: Core Technologies Expand Opportunities for Cell Therapy Manufacturing

S. Anne Montgomery

September 16, 2015

1 Min Read

AtE-intro-300x206.jpgPall Life Sciences has long been known for its expertise in processing and filtration equipment for the biopharmaceutical industry. In recent years, the company has broadened its offerings in upstream manufacturing by expanding its core capabilities in the single-use, bioreactor, and microcarrier arenas, with unique and innovative technologies for cultivation of cells to be used as therapies.

Read the full text of this article in the PDF (Login required).

You May Also Like